Babies born with Retinopathy of prematurity (ROP), one of the most common causes of vision loss in children, stand to benefit from an exciting discovery made possible, in part, by Fighting Blindness Canada. The…

Clinical trials of valproic acid for the treatment of retinitis pigmentosa began in both the USA and Korea in late 2011. As well, a smaller shorter open-label trial was begun in Japan….

In January, follow-up results from the first six months of the British choroideremia gene therapy trial were published. At the Association for Vision Research and Ophthalmology meeting today, the team led by Dr. Robert…

The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…

1. Can you share with us what retinal eye disease you have and when you were diagnosed? The retinal disease I have is called Stargardt’s. It is when one has no central…

Can you share with us what retinal eye disease you have and when you were diagnosed? Retinitis Pigmentosa – 5 years old Did vision loss have any impact on your education choices?…